Science Explorer Back to mapMap
Discussion
Topic · Nephrology

Dialysis and Renal Disease Management

Dialysis and Renal Disease Management is a research topic within Nephrology. Science Explorer counts 51k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on chronic kidney disease, dialysis treatment, and associated complications such as inflammation, cardiovascular disease, and malnutrition. It explores the impact of dialysis dose, intradialytic hypotension, uremic toxins, and the role of nutrition in improving outcomes and quality of life for patients. The cluster also addresses the epidemiology of kidney disease and mortality risk factors in hemodialysis and peritoneal dialysis patients.

  • Dialysis
  • Chronic Kidney Disease
  • Inflammation
  • Mortality
  • Hemodialysis
  • Peritoneal Dialysis
  • Cardiovascular Disease
  • Nutrition
  • Uremic Toxins
  • Quality of Life
Research works
51k
fractional, since 1950
In the world top 10%
5.1k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+24%
the tick is no change
Largest producer
United States
28% of the 10 largest, 2022-now
Dialysis and Renal Disease Management

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Dialysis and Renal Disease Management research?

By volume, the United States and China publish the most (2.2k and 1.9k works in 2022-now).

By volume, 2022-now

  1. 1 United States 2.2k works
  2. 2 China 1.9k works
  3. 3 Japan 684 works
  4. 4 India 520 works
  5. 5 Brazil 515 works
  6. 6 United Kingdom 508 works
  7. 7 Spain 356 works
  8. 8 Türkiye 326 works
  9. 9 Italy 322 works
  10. 10 Canada 322 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 28.5%China: 25.1%Japan: 8.9%India: 6.8%6 others listed: 30.7%28%largest
United States2,174 · 28.5%China1,915 · 25.1%Japan684 · 8.9%India520 · 6.8%6 others listed2,348 · 30.7%

Shares of the rows listed above, not of the whole node.

Which institutions lead Dialysis and Renal Disease Management research?

By volume in 2022-now, Sichuan University publishes the most Dialysis and Renal Disease Management research, followed by Sun Yat-sen University and Harvard University.

By volume, 2022-now

  1. 1 Sichuan UniversityChina 70 works
  2. 2 Sun Yat-sen UniversityChina 63 works
  3. 3 Harvard UniversityUnited States 62 works
  4. 4 University of TorontoCanada 59 works
  5. 5 Shanghai Jiao Tong UniversityChina 53 works
  6. 6 Johns Hopkins UniversityUnited States 51 works
  7. 7 Peking UniversityChina 50 works
  8. 8 United States Department of Veterans AffairsUnited States 49 works
  9. 9 Nanjing Medical UniversityChina 48 works
  10. 10 The University of SydneyAustralia 48 works

Who are the leading researchers in Dialysis and Renal Disease Management?

The most-cited researchers publishing on Dialysis and Renal Disease Management include Theo Vos, Ali H. Mokdad and Walter Churchill Willett.

  1. 1 Theo Vos United States 439k citations
  2. 2 Ali H. Mokdad United States 429k citations
  3. 3 Walter Churchill Willett United States 411k citations
  4. 4 Jost Bruno Jonas Germany 350k citations
  5. 5 John J.V. McMurray United Kingdom 349k citations
  6. 6 Hermann Brenner Germany 343k citations
  7. 7 Emelia J. Benjamin United States 341k citations
  8. 8 Giuseppe Remuzzi Italy 328k citations
  9. 9 Mika Kivimäki United Kingdom 318k citations
  10. 10 Gordon Henry Guyatt Canada 315k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Dialysis and Renal Disease Management?

The most cited paper in Dialysis and Renal Disease Management is "A New Equation to Estimate Glomerular Filtration Rate" (Andrew S. Levey, Lesley A. Stevens, Christopher H. Schmid et al., 2009), with 26,119 citations. Next come "A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation" (15,196) and "Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease?" (11,736).

Most cited papers
#PaperReleasedCitations
1 A New Equation to Estimate Glomerular Filtration Rate Andrew S. Levey, Lesley A. Stevens, Christopher H. Schmid et al. · Annals of Internal Medicine Open access 5 May 2009 26,119
2 A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation Andrew S. Levey, Juan P. Bosch, Julia Breyer Lewis et al. · Annals of Internal Medicine 16 Mar 1999 15,196
3 Should We STOP Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptor Blockers in Advanced Kidney Disease? Aimun Ahmed, Tom Jorna, Sunil Bhandari · ˜The œNephron journals/Nephron journals 2016 11,736
4 Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization Alan S. Go, Glenn Matthew Chertow, Dongjie Fan et al. · New England Journal of Medicine Open access 22 Sep 2004 11,467
5 Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate Andrew S. Levey, Josef Coresh, Tom Greene et al. · Annals of Internal Medicine 15 Aug 2006 5,794
All 100 most cited papers, with filters and sorting

Where is Dialysis and Renal Disease Management research done?

The largest centres of Dialysis and Renal Disease Management research in 2022-now are Beijing (China), Tokyo (Japan), Guangzhou (China) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Bad Homburg and Waltham.

Largest cities, 2022-now

  1. 1 BeijingChina 218 works
  2. 2 TokyoJapan 190 works
  3. 3 GuangzhouChina 164 works
  4. 4 ShanghaiChina 163 works
  5. 5 SeoulSouth Korea 146 works
  6. 6 LondonUnited Kingdom 142 works
  7. 7 São PauloBrazil 137 works
  8. 8 New YorkUnited States 126 works
  9. 9 ChengduChina 107 works
  10. 10 Mexico CityMexico 102 works

Where it is the local speciality

  1. Bad HomburgDE · 35.1 works128×
  2. WalthamUS · 45.1 works18×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Dialysis and Renal Disease Management than the world average.

See Dialysis and Renal Disease Management on the map

Where is the best place to study Dialysis and Renal Disease Management?

Among universities, judged by research, Sichuan University, Harvard University and Karolinska Institutet score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 19.57%fractional works in this field (log) →share of work in the world top 10% →Sichuan UniversityUniversity of Gronin…Karolinska InstitutetHarvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Sichuan UniversityChina 75.522.6%2.9×70 +101.2%
2Harvard UniversityUnited States 72.116.4%1.9×62 +13.2%
3Karolinska InstitutetSweden 71.720.3%6.1×36 +16.2%
4University of GroningenNetherlands 70.022.4%4.0×29 +16.3%
5Southern Medical UniversityChina 66.719.7%5.7×37 +70.7%
6Nanjing Medical UniversityChina 65.116.6%5.1×48 +83.5%
7Central South UniversityChina 64.724.6%1.8×36 +99.2%
8The University of SydneyAustralia 64.513.2%3.7×48 +3.7%
9Johns Hopkins UniversityUnited States 63.514.6%3.1×51 -12.8%
10Guangzhou University of Chinese MedicineChina 63.325.3%8.3×21 +97.8%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Dialysis and Renal Disease Management, country by country

Is Dialysis and Renal Disease Management research growing?

Output in 2022-2025 was 24% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Dialysis and Renal Disease Management.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Dialysis and Renal Disease Management as a percentage of every work published that year, 0.049% in 2024.

still counting0.020%0.040%0.060%Dialysis and Renal Disease Management0.055% in 202519801990200020102020

Fractional works of Dialysis and Renal Disease Management over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Dialysis and Renal Disease Management9.9% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Dialysis and Renal Disease Management. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.